BioIntelliSense Acquires AlertWatch® Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions
businesswire.com
news
2022-10-18 00:00:00

October 18, 2022 07:00 AM Eastern Daylight Time DENVER--(BUSINESS WIRE)--BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced its acquisition of AlertWatch®, an FDA-cleared, clinically proven patient monitoring solution. AlertWatch uniquely provides robust integration, data analysis and a patented intuitive display of contextual patient data for more efficient, actionable clinical decisions. As part of the recently announced strategic partnership with Medtronic, its Patient Monitoring business will distribute AlertWatch to hospitals throughout the U.
